Subhash Thuluva

4PUBLICATIONS
6CO-AUTHORS
Infant and child healthNeonatologyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 25, 2026
Safety, Immunogenicity of Co-Administered Vaccines, and Lot-to-Lot Consistency of a 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14®) Administered at 6-10-14 Weeks in Healthy Infants: A Multicenter, Phase IV Trial.

|Apr 27, 2026
Immunogenicity and Safety of Biological E's Monovalent rDNA Hepatitis B Vaccine (BEVAC®) in Neonates and Infants: A Multicentre, Randomized, Phase IV Non-Inferiority Trial.

|Apr 28, 2023
Immunogenicity and safety of Biological E's CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trial.

Subhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri

|Mar 25, 2022
A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator.

Subhash Thuluva, Vikram Paradkar, Ramesh Matur

Pageof 1

Frequent Collaborators

2 joint publications

Siddalingaiah Ningaiah

2 joint publications

Kamal Thammireddy

1 joint publications

Kishore Turaga

1 joint publications

Raju Esanakarra